Street signs: CPSE short-sellers trapped, Nifty near 12,000, and more

Most of them had to cover their short positions after the CPSE ETF FFO garnered over five times subscription

markets
markets
Ashley CoutinhoSamie Modak Mumbai
2 min read Last Updated : Mar 31 2019 | 8:48 PM IST
Rally may take Nifty near 12,000 

The Nifty clocked gains of 7.3 per cent in the March series to close at 11,570. Rollovers were higher compared to the previous two months with better rollover costs. The longs have rolled over their positions to the next series and the momentum could take the index to 11,760 levels and higher as part of a pre-election rally. The Bank Nifty gained 13.5 per cent to 30,420 and there continues to be a buying interest in both private and public sector banks, said derivatives experts. The Bank Nifty needs to hold above the 29,888 zone to extend the rally towards 31,000, they said.

Ashley Coutinho

CPSE short-sellers trapped

Many traders were caught off-guard by the high investor demand in the CPSE ETF follow-on fund offer (FFO). According to industry players, traders had built arbitrage positions by shorting the 10 underlying stocks and by applying in the FFO, where units were offered at a discount of 4 per cent. Most of them had to cover their short positions after the CPSE ETF FFO garnered over five times subscription. “Traders feared that they may not get the desired allotment and their bets could go awry,” said a broker. Interestingly, most PSU stocks had rallied sharply on the back of short-covering on Monday even as the benchmark Sensex had declined as much as 500 points due to risk aversion created by the yield curve inversion in the US.

Samie Modak

Tepid grey market IPO premiums

Grey market operators don’t seem to be enthused by the initial public offers (IPOs) of Metropolis Healthcare and Rail Vikas Nigam. According to market players, shares of both the companies are quoting at low single-digit premiums in the grey market. State-owned Rail Vikas’ Rs 481 crore IPO closes on Wednesday, the same day when diagnostics company Metropolis Healthcare’s Rs 1,200 crore IPO opens. However, experts say the low premiums are not good indicators for the IPO prospects of the two companies. “Due to the lull in the primary market, many operators are not active. As a result, grey market premiums may not be the right way to judge these stocks,” said a broker.
Samie Modak

One subscription. Two world-class reads.

Already subscribed? Log in

Subscribe to read the full story →
*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

Next Story